Please wait, the image is uploading...
The uploaded image must not exceed 20 MB. Acceptable formats: .jpg, .jpeg, .png, .webp
The summary is based on the profile data provided by the startup
Limited Access
Limited Access
Limited Access
Limited Access
Based on average growth forecasts from Equidam, which analyzed 140,000 early-stage venture companies worldwide
Learn moreLimited access
This data is under wraps
Sensitive data for this profile is visible only to subscribers. Subscribe to unlock and view full details.
Sensitive data for this profile is visible only to subscribers. Subscribe to unlock and view full details.
Sensitive data for this profile is visible only to subscribers. Subscribe to unlock and view full details.
Limited access
This data is under wraps
PALTECH is a Biotech / Medtech for Life science sector, helping them the remission of Type 2 Diabetes and Obesity through a revolutianary treatment
Paltech, a start-up developing a revolutionary treatment for type 2 diabetes and obesity. Despite the success of recent drugs, hundreds of millions of type 2 diabetes patients still suffer from treatment failures, resulting in high mortality rates and costly morbidities. Their vision is to enable type 2 diabetes and obesity to go into remission for at least 5 years, thanks to a drug-carrying implant. Preclinical studies show spectacular results in terms of efficacy.
Limited Access
Limited Access
followed by:
bages:
No achievements or badges added yet
8 key updates
Last updated: 15 March
